Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Device Type & End-User The global closed system transfer devices market will witness a robust CAGR of 19.2%, valued at $785.24 million in 2021, expected to appreciate and reach $3.8 billion by 2030, confirms Strategic Market Research. National Institute of Standards & Technology explains a Closed System Drug-Transfer Device (CSTD) as "a medication transfer device that mechanically prevents external pollutants from entering the system and hazardous vapour or drug concentrations from escaping outside the system." CSTDs now use one of two design principles to restrict the escape of hazardous medications into the work environment: a physical barrier or an air-cleaning device. CSTDs provide improved protection to healthcare professionals against potentially hazardous exposures during the compounding and administration of hazardous medications when properly developed and administered. If we observe the various components in this market, the syringe safety devices take the largest share of 36% followed by vial access devices which hold an estimated 32% share in this market. The COVID-19 virus led to widespread vaccination campaigns around the world thereby boosting the market for closed-system transfer devices. The article "Needle-Free Jet Injection System for Repeated Biopharmaceutical Delivery and Controlled Release," published in the journal Pharmaceuticals in November 2021, investigated the successful working & design model of an air-driven, needle-free jet injector, a kind of needleless, closed system transfer device for use at the time of large number of COVID-19 vaccinations. The model has a medication transfer efficiency of 97.8% at 0.5 mL/shot and a drug delivery efficiency of 96.7% at 0.2 mL/shot. There are two types of closed-system transfer devices: membrane-to-membrane and needless systems. The membrane-to-membrane type hold a significant position with a share of around 70%. Membrane-to-membrane systems are simple to use, less prone to contamination and can be employed with current devices. Additionally, the needless system is also expected to be the fastest-growing sector. The rise in oncological drug development and the rise in novel medication approvals can both be linked to the expansion of the closed system transfer devices (CSTD) market globally. The overall number of annual innovative medicine approvals grew from 22 in 2016 to 50 in 2021, as per statistics from the Center for Drug Evaluation and Research (CDER) of the United States Food and Drug Administration (FDA). In addition, the numbers showed that between 2012 and 2021, there were 43 approvals of innovative drugs annually on an average. In 2020, North America had the largest revenue of $260.21 million, and by the end of 2030, that figure is estimated to reach $1170.3 million due to the rising cases of cancer in the area. Furthermore, Europe was the second largest market, with a revenue of $241.45 million in 2020, and by 2030 it will reach $1065.80 million. CSTD (Closed System Transfer Devices) is a drug transfer device that prevents the transfer of environmental contamination in the medical systems and escaping hazardous vapor concentrations outside the system. Closed-system transfer devices (CSTDs) are methods used for transferring medication from one reservoir to another while limiting the potential for drug contamination, drug aerosolization, hazardous drug exposure, and sharps exposure. According to a review in 2013, it was discovered that the price of developing a delivery system was only 10% of the total cost of development of a new pharmaceutical. A more recent study in 2020 discovered that the overall price of launching a new drug to market was approximately $985 million, excluding the total cost of developing drug delivery systems. Among the oncologists from all across the world, 65.75% of doctors said that they would prefer chemotherapy to treat cancer. In 2020, approximately 1.8 million new cancer cases were diagnosed, and about 606,520 cancer deaths occurred in the United States. Also, in the United States Each year, almost 650,000 cancer patients receive chemotherapy treatment United States. Some of the most efficient and FDA approved CSTDs include PhaSeal (Bector and Dickinson, US), Arisure (Yukon Medical, US), Tevadaptor (Simplivia Healthcare, Israel), Chemfort (Simplivia Healthcare, Israel), Halo (Corvida, US), ChemoClave (ICU Medical, US), ChemoLock (ICU Medical, US), Equashield II (Equashield, US), NeoShield (JMS, Japan & US). Impact of COVID-19 The COVID-19 pandemic has adversely impacted the CSTD market. Nationwide lockdown and social distancing have caused a deferral of millions of innovative and highly efficient processes, thereby resulting in a potential backlog of case volume. Because of this, the average footfall in hospitals has decreased drastically, and many hospitals postponed non-emergency procedures. In addition, due to the widespread of COVID-19, diagnosis and treatment have become a more significant concern worldwide. Market Drivers: - The rising number of cancer cases all over the world is one of the prime factors that is driving the growth of this market. It has resulted in a healthy increase in the adoption of chemotherapy treatments worldwide. According to WHO, in 2020, cancer has caused over 10 million deaths across the world. Also, IARC and WHO have estimated that the number of cancer cases all around the world will rise to 19.3 million by 2025.Moreover, a rapid increase in the number of oncology drug approvals is also one of the significant factors that highly stimulate this market's growth efficiently. Restraints: - The higher price of implementations of CSTDs and a lack of reimbursement policies are the two major factors restraining the overall growth of this market across the world. In addition, many small hospitals don't have the financial capability to purchase this device, owing to which most of them do not opt for CSTDs. Opportunities: - Cytotoxic drugs are designed to destroy the cells that grow in a rapid and uncontrolled manner. The use of this drug is increasing rapidly in the healthcare sectors across the world and is expected to increase abruptly in the upcoming years. The Cytotoxic Drugs Market size was valued at USD 12.173 million in 2020 and is expected to reach up to USD 20.187 million by 2028, growing at a CAGR of 6.73% Also, various non-cytotoxic drugs like Bacillus of Calmette, monoclonal antibodies, and the Guerin strain of Mycobacterium Bovis (BCG) are in high demand and are expected to grow at a rapid rate in the future. Market Analysis Of Different Segments Covered in the Report Based on Device Type Membrane-To-Membrane Systems Needleless Systems Based on Closing Mechanism Luer-Lock Systems Color-To-Color Alignment Systems Click-To-Lock Systems Push-To-Turn Systems Based on Technology Diaphragm-Based Devices Compartmentalized Devices Air Cleaning/Filtration Devices Based on Components Vial Access Devices Syringe Safety Devices Bag/Line Access Devices Accessories Based on End Users Hospitals Oncology Centers Other Regional Coverage Analysis North America US Mexico Canada Rest of North America Europe Switzerland France U.K Germany Finland Netherlands Russia Belgium Spain Turkey Italy Rest of Europe Asia Pacific China India Japan South Korea Malaysia Singapore Thailand Australia Indonesia Philippines Rest of Asia-Pacific LAMEA Brazil Argentina Uruguay Saudi Arabia Rest of LAMEA Based on Device Type, the 'Membrane-To-Membrane Systems' segment accounted for the highest share of approximately 70.73% of the CSTDs market. This segment accounted for up to USD 459.1 million in 2020 and is growing rapidly at a CAGR of 20.6%. The biggest share of this segment is due to their ease of operation and a lower risk of contamination associated with Double Membrane Containment Systems. Based on Closing Mechanism, the 'Luer-Lock Systems' segment accounted for the largest share of 33.24 % of the market. This segment is valued at up to USD 213.31 million in 2020, at a CAGR of 19.17%. The 'Color-To-Color Alignment Systems' segment is the fastest-growing segment because of its higher efficiency due to pressure equalization mechanisms and lower cost. Based on Technology, the 'Diaphragm-Based Devices Segment' accounted for the highest share of 42.78% of the market. This segment was valued at up to USD 286.54 million in 2020, at a CAGR of 18.75%. The highest share of this segment is mainly due to the ease of operation and quality of safety provided. The 'Compartmentalized Devices' segment is growing at the fastest rate with a CAGR of 23.57% over the forecast period because of their lower cost. Based on Components, the 'Vial Access Devices' segment held the maximum share of about 32.53 % of the market. The highest percentage of share of this segment is because of the increasing adoption of CSTD products and vial access devices by oncology doctors. Based on End-User, the 'Hospitals & Clinics' accounted for the largest share of 83.71% of the CSTDs market. The largest percentage of this segment is primarily because of the strong financial capacity of the hospitals for purchasing expensive CSTDs, and the urgent need for regulatory guidelines. Based on Regions, North America held the highest share of the market due to easy accessibility to the advanced and modernized technologies, rising awareness of CSTD among nurses, oncologists, and pharmacists, the existence of many key CSTD manufacturing players in this region, and the continued prevalence of cancer. However, The Asia-Pacific region is growing at the fastest rate with a CAGR of 21.57% over the forecasted period. Continuous increase of cancer cases, increasing demand for better healthcare services, and the focus of key international players such as China and India are fuelling the growth of the Asia Pacific market. Closed System Transfer Device Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 785.24 Million The revenue forecast in 2030 USD 3.8 Billion Growth rate CAGR of approximately 19.2% The base year for estimation 2021 Historical data 2017 – 2021 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based on Device Type, Closing Mechanism, Technology, Components, End Users, Based on Regions. Based on Device Type Membrane-To-Membrane Systems Needleless Systems Based on Closing Mechanism Luer-Lock Systems, Color-To-Color Alignment Systems, Click-To-Lock Systems, Push-To-Turn Systems Based on Technology Diaphragm-Based Devices, Compartmentalized Devices, Air Cleaning/Filtration Devices Based on Components Vial Access Devices, Syringe Safety Devices, Bag/Line Access Devices, Accessories End Users Hospitals, Oncology Centers, Other By Region North America, Europe, Asia Pacific, Rest of Asia Pacific Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Dickinson and Company, Becton, Corvida Medical, B. Braun Melsungen, ICU Medical, JMS, Equashield, Corvida Medical, Yukon Medical, Simplivia Healthcare, CODAN Medizinische Geräte, Caragen, VICTUS, Baxter International. Closed System Transfer Device Market Competitive Landscape Analysis Competitive landscape analysis provides the most accurate details on the notable competitors existing in the market environment all across the world. The comparison is performed based on the global presence, market capability, overall revenue generated, expenditure in the field of R&D, production capacity, market initiatives, company overview and financials, organization flaws and strengths, production sites and facilities, etc. Dickinson and Company Becton Corvida Medical B. Braun Melsungen ICU Medical JMS Equashield Corvida Medical Yukon Medical Simplivia Healthcare CODAN Medizinische Geräte Caragen VICTUS Baxter International Recent Developments On January 2021, Simplivia Healthcare obtained a 70% share of NOVAMED, a diagnostic company that efficiently manufactures and develops a range of diagnostic kits to meet the evolving trends of home care adequately. On May 2021, Bector and Dickinson further expanded its drug delivery devices segment by establishing a high-tech manufacturing facility located in Spain. On March 2021, Yukon Medical launched FDA-approved closed system transfer device Arisure under the ONB product classification. Frequently Asked Question About This Report Who all are the leading industry players in the Closed System Transfer Device Market? The leading players of this market include Becton, Dickinson and Company, ICU Medical, B. Braun Melsungen, JMS, Simplivia Healthcare, Corvida Medical, Yukon Medical Baxter International, etc. What is the overall share of the Closed System Transfer Devices Market? The Closed System Transfer Devices Market Share was valued at USD 785.24 million in 2021 and is expected to reach a landmark of USD 3.8 billion by 2030, with a rapid CAGR of 19.2% over the forecasted period of 2021-2030. What are the most notable trends that are currently dominating the market? The most dominating trends of the CSTD market include automated compounding of hazardous drugs by implementing high-quality robotic systems and the new technologies for rapid detection tests to simulate routine monitoring. Which is the most dominant device technology in the CSTD market? Based on Technology, the CSTD market is classified into Diaphragm-Based Devices, Compartmentalized Devices, Air Cleaning/Filtration Devices. The Diaphragm-Based Devices Segment accounted for the highest share of 42.78% of the market. This segment was valued at up to USD 785.24 million in 2021, at a CAGR of 18.75%. Which is the most dominating region of the market? North America is the most dominating region of the CSTD market. Which is the most dominant device technology in the CSTD market? Based on Technology, the CSTD market is classified into Diaphragm-Based Devices, Compartmentalized Devices, Air Cleaning/Filtration Devices. The Diaphragm-Based Devices Segment accounted for the highest share of 42.78% of the market. This segment was valued at up to USD 785.24 million in 2021, at a CAGR of 18.75%. How big is closed system transfer devices market? The closed system transfer devices market size was valued at USD 785.24 million in 2021 and is expected to reach a landmark of USD 3.8 billion by 2030 Sources https://pubs.rsc.org/en/content/chapterhtml/2015/bk9781782621898-00001?isbn=978-1-78262-189-8 https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2020.html https://www.who.int/news-room/fact-sheets/detail/cancer Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Market Segmentation 1.3.2 Geographic Scope Figure 02: Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure5: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table2: Risk Assessment Chapter 3. Executive Summary 3.1 Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Market, 2021–2030 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Market, 2021–2030 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Market, 2021–2030(USD Million) 3.1.4 Market Summary Figure 10: Membrane-To-Membrane Systems to Witness Highest CAGR in Market, By Device Type, During Forecast Period Figure 11: Luer-Lock Systems to Witness Higher CAGR in Market for Closing Mechanism Segment during Forecast Period Figure 12: Diaphragm-Based Devices Segment for Technology to Register Highest CAGR in Market during Forecast Period Figure 13: Vial Access Devices to Witness Higher CAGR in Market for Components Segment during Forecast Period Figure 14: Hospitals & Clinics for End Users to Register Highest CAGR in Market during Forecast Period Figure 15: North America to Account for Largest Share of Global Market In 2021 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 16: Market Segmentation Chapter 5. Industry Outlook 5.1 Global Closed System Transfer Device Market Snapshot 5.2 Global Market 5.2.1 Global Market, 2021 – 2030 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Market, by region, 2021 - 2030 (USD Million) 5.4 Device Type Segment Analysis 5.4.1 Global Market, by Device Type, 2021 - 2030 (USD Million) 5.5 Closing Mechanism Segment Analysis 5.5.1 Global Market, By Closing Mechanism, 2021 - 2030 (USD Million) 5.6 Technology Segment Analysis 5.6.1 Global Market, by Technology, 2021 - 2030 (USD Million) 5.7 By Technology Business Analysis 5.8 Value Chain Analysis 5.9 Market Variable Analysis 5.9.1 Market Drivers Analysis 5.9.2 Market Restraints Analysis 5.10 Business Environment Analysis Tool 5.10.1 Market PEST analysis 5.10.2 Market Porter’s analysis 5.11 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 18 Market Drivers and Their Impact 6.2.2 Restraints Figure 19 Market Restraints and Their Impact 6.2.3 Opportunities Figure 20 Market Opportunities and Their Impact 6.2.4 Challenges Figure 21 Market Challenges and Their Impact 6.3 Impact of Covid-19 on Market 6.4 Value Chain Analysis Figure 22 Value Chain Analysis: Market 6.5 Ecosystem Figure 23 Market: Ecosystem Table 3 Market: Ecosystem Figure 24 Revenue Shift in Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Market in USA in Last 9 Years Figure 25 Top 14 Companies with Highest No. of Patents in Last 9 Years Figure 26 No of Patents Granted Per Year, 2019–2021 Table 5 List of Global Patents in Market 6.7 Trade Analysis 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 6 Market: Porter’s Five Forces Analysis, 2021 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2021) 6.11.2 Trends in Technology (2021-2030) Table 7 Key Regulations: Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 8: Key Players market share Figure27: Key players market share of companies 7.2 Manufacturers Closed System Transfer Device Manufacturing Sites, Area Served, Product Device Type 7.3 Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Market: Device Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2021-2030) Table 8 Market, By Device Type, 2021–2030 (USD Million) Figure 28 Market, By Device Type Figure 29 Membrane-To-Membrane Systems Segment to Register Highest CAGR in Market During Forecast Period 8.3 Membrane-To-Membrane Systems 8.3.1 Membrane-To-Membrane Systems market, 2021 - 2030 (USD Million) Figure 30: Membrane-To-Membrane Systems market, 2021 - 2030 (USD Million) 8.4 Needleless Systems 8.4.1 Needleless Systems market, 2021 - 2030 (USD Million) Figure 31: Needleless Systems market, 2021 - 2030 (USD Million) Chapter 9. Global Market: Closing Mechanism Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2021-2030) Table 9: Market, By Closing Mechanism, 2021–2030 (USD Million) Figure 32: Market, By Closing Mechanism, 2021–2030 (USD Million) Figure 33: Luer-Lock Systems Segment to Register Highest CAGR in Market during Forecast Period 9.3 Luer-Lock Systems 9.3.1 Luer-Lock Systems market, 2021 - 2030 (USD Million) Figure 34: Luer-Lock Systems market, 2021 - 2030 (USD Million) 9.4 Color-To-Color Alignment Systems 9.4.1 Color-To-Color Alignment Systems market, 2021 - 2030 (USD Million) Figure 35: Color-To-Color Alignment Systems market, 2021 - 2030 (USD Million) 9.5 Click-To-Lock Systems 9.5.1 Click-To-Lock Systems market, 2021 - 2030 (USD Million) Figure 36: Click-To-Lock Systems market, 2021 - 2030 (USD Million) 9.6 Push-To-Turn Systems 9.6.1 Push-To-Turn Systems market, 2021 - 2030 (USD Million) Figure 37: Push-To-Turn Systems market, 2021 - 2030 (USD Million) Chapter 10. Global Market: Technology Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2021-2030) Table 10: Market, By Technology, 2021–2030 (USD Million) Figure 38: Market, By Technology, 2021–2030 (USD Million) Figure 39: Diaphragm-Based Devices to Register Highest CAGR in Market during Forecast Period 10.3 Diaphragm-Based Devices 10.3.1 Diaphragm-Based Devices market, 2021 - 2030 (USD Million) Figure 40: Diaphragm-Based Devices market, 2021 - 2030 (USD Million) 10.4 Compartmentalized Devices 10.4.1 Compartmentalized Devices market, 2021 - 2030 (USD Million) Figure 41: Compartmentalized Devices market, 2021 - 2030 (USD Million) 10.5 Air Cleaning/Filtration Devices 10.5.1 Air Cleaning/Filtration Devices Technology market, 2021 - 2030 (USD Million) Figure 42: Air Cleaning/Filtration Devices Technology market, 2021 - 2030 (USD Million) Chapter 11. Global Market: Components Segment Analysis 11.1 Introduction 11.2 Sales Volume & Revenue Analysis (2021-2030) Table 11: Market, By Components, 2021–2030 (USD Million) Figure 43: Market, By Components, 2021–2030 (USD Million) Figure 44: Vial Access Devices Segment to Register Highest CAGR in Market during Forecast Period 11.3 Vial Access Devices 10.3.1 Vial Access Devices market, 2021 - 2030 (USD Million) Figure 45: Vial Access Devices market, 2021 - 2030 (USD Million) 11.4 Syringe Safety Devices 11.4.1 Syringe Safety Devices market, 2021 - 2030 (USD Million) Figure 46: Syringe Safety Devices market, 2021 - 2030 (USD Million) 11.5 Bag/Line Access Devices 11.5.1 Bag/Line Access Devices Components market, 2021 - 2030 (USD Million) Figure 47: Bag/Line Access Devices Components market, 2021 - 2030 (USD Million) 11.6 Accessories 11.6.1 Accessories Components market, 2021 - 2030 (USD Million) Figure 48: Accessories Components market, 2021 - 2030 (USD Million) Chapter 12. Global Market: End Users Segment Analysis 12.1 Introduction 12.2 Sales Volume & Revenue Analysis (2021-2030) Table 12: Market, By End Users, 2021–2030 (USD Million) Figure 49: Market, By End Users, 2021–2030 (USD Million) Figure 50: Hospitals Segment to Register Highest CAGR in Market during Forecast Period 12.3 Hospitals 12.3.1 Hospitals market, 2021 - 2030 (USD Million) Figure 51: Hospitals market, 2021 - 2030 (USD Million) 12.4 Oncology Centers 12.4.1 Oncology Centers market, 2021 - 2030 (USD Million) Figure 52: Oncology Centers market, 2021 - 2030 (USD Million) 12.5 Other 12.5.1 Other End Users market, 2021 - 2030 (USD Million) Figure 53: Other End Users market, 2021 - 2030 (USD Million) Chapter 13. Global Market: Regional Outlook 13.1 North America Figure 54: North America Market, By Revenue Forecast (2021-2030) 13.1.1 North America Market, by country, 2021 - 2030 (USD Million) Table 13: North America Market, by Country, 2021-2030 Figure 55: North America Market 13.1.2 North America Market, by Device Type, 2021 - 2030 (USD Million) Table14: North America Market, by Device Type, 2021 - 2030 (USD Million) Figure 56: North America Market, by Device Type, 2021 - 2030 (USD Million) 13.1.3 North America Market, by Closing Mechanism, 2021 - 2030 (USD Million) Table 15: North America Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 57: North America Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.1.4 North America Market, by Technology, 2021 - 2030 (USD Million) Table 16: North America Market, by Technology, 2021 - 2030 (USD Million) Figure 58: North America Market, by Technology, 2021 - 2030 (USD Million) 13.1.5 U.S. 13.1.5.1 U.S. Market, by Device Type, 2021 - 2030 (USD Million) Figure 59: U.S. Market, by Device Type, 2021 - 2030 (USD Million) 13.5.2 U.S. Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 60: U.S. Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.1.5.3 U.S. Market, by Technology, 2021 - 2030 (USD Million) Figure 61: U.S. Market, by Technology, 2021 - 2030 (USD Million) 13.1.6 Canada 13.1.6.1 Canada Market, by Device Type, 2021 - 2030 (USD Million) Figure 62: Canada Market, by Device Type, 2021 - 2030 (USD Million) 13.1.6.2 Canada Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 63: Canada Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.1.6.3 Canada Market, by Technology, 2021 - 2030 (USD Million) Figure 64: Canada Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.1.6.4 Canada Market, by Technology, 2021 - 2030 (USD Million) Figure 65: Canada Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.2 Europe Figure 66: Europe Market, By Revenue Forecast (2021-2030) 13.2.1 Europe Market, by country, 2021 - 2030 (USD Million) Table 17: Europe Market, by country, 2021 - 2030 (USD Million) Figure 67: Europe Market, by country, 2021 - 2030 (USD Million) 13.2.2 Europe Market, by Device Type, 2021 - 2030 (USD Million) Table 18: Europe Market, by Device Type, 2021 - 2030 (USD Million) Figure 68: Europe Market, by Device Type, 2021 - 2030 (USD Million) 13.2.3 Europe Market, by Closing Mechanism, 2021 - 2030 (USD Million) Table 19: Europe Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 69: Europe Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.2.4 Europe Market, by Technology, 2021 - 2030 (USD Million) Table 20: Europe Market, by Technology, 2021 - 2030 (USD Million) Figure 70: Europe Market, by Technology, 2021 - 2030 (USD Million) 13.2.5 U.K. 13.2.5.1 U.K. Market, by Device Type, 2021 - 2030 (USD Million) Figure 71: U.K. Market, by Device Type, 2021 - 2030 (USD Million) 13.2.5.2 U.K. Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 72: U.K. Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.2.5.3 U.K. Market, by Technology, 2021 - 2030 (USD Million) Figure 73: U.K. Market, by Technology, 2021 - 2030 (USD Million) 13.2.6 Germany 13.2.6.1 Germany Market, by Device Type, 2021 - 2030 (USD Million) Figure 74: Germany Market, by Device Type, 2021 - 2030 (USD Million) 13.2.6.2 Germany Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 75: Germany Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.2.6.3 Germany Market, by Technology, 2021 - 2030 (USD Million) Figure 76: Germany Market, by Technology, 2021 - 2030 (USD Million) 13.2.7 France 13.2.7.1 France Market, by Device Type, 2021 - 2030 (USD Million) Figure 77: France Market, by Device Type, 2021 - 2030 (USD Million) 13.2.7.2 France Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 78: France Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.2.7.3 France Market, by Technology, 2021 - 2030 (USD Million) Figure 79: France Market, by Technology, 2021 - 2030 (USD Million) 13.2.8 Rest of Europe 13.2.8.1 Rest of Europe Market, by Device Type, 2021 - 2030 (USD Million) Figure 80: Rest of Europe Market, by Device Type, 2021 - 2030 (USD Million) 13.2.8.2 Rest of Europe Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 81: Rest of Europe Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.2.8.3 Rest of Europe Market, by Technology, 2021 - 2030 (USD Million) Figure 82: Rest of Europe Market, by Technology, 2021 - 2030 (USD Million) 13.3 Asia Pacific Figure 83: Asia Pacific Market, By Revenue Forecast (2021-2030) 13.3.1 Asia Pacific Market, by country, 2021 - 2030 (USD Million) Table 21: Asia Pacific Market, by country, 2021 - 2030 (USD Million) Figure 84: Asia Pacific Market, by country, 2021 - 2030 (USD Million) 13.3.2 Asia Pacific Market, by Device Type, 2021 - 2030 (USD Million) Table 22: Asia Pacific Market, by Device Type, 2021 - 2030 (USD Million) Figure 85: Asia Pacific Market, by Device Type, 2021 - 2030 (USD Million) 13.3.3 Asia Pacific Market, by Closing Mechanism, 2021 - 2030 (USD Million) Table 23: Asia Pacific Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 86: Asia Pacific Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.3.4 Asia Pacific Market, by Technology, 2021 - 2030 (USD Million) Table 24: Asia Pacific Market, by Technology, 2021 - 2030 (USD Million) Figure 87: Asia Pacific Market, by Technology, 2021 - 2030 (USD Million) 13.3.5 China 13.3.5.1 China Market, by Device Type, 2021 - 2030 (USD Million) Figure 88: China Market, by Device Type, 2021 - 2030 (USD Million) 13.3.5.2 China Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 89: China Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.3.5.3 China Market, by Technology, 2021 - 2030 (USD Million) Figure 90: China Market, by Technology, 2021 - 2030 (USD Million) 13.3.6 India 13.3.6.1 India Market, by Device Type, 2021 - 2030 (USD Million) Figure 91: India Market, by Device Type, 2021 - 2030 (USD Million) 13.3.6.2 India Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 92: India Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.3.6.3 India Market, by Technology, 2021 - 2030 (USD Million) Figure 93: India Market, by Technology, 2021 - 2030 (USD Million) 13.3.7 Japan 13.3.7.1 Japan Market, by Device Type, 2021 - 2030 (USD Million) Figure 94: Japan Market, by Device Type, 2021 - 2030 (USD Million) 13.3.7.2 Japan Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 95: Japan Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.3.7.3 Japan Market, by Technology, 2021 - 2030 (USD Million) Figure 96: Japan Market, by Technology, 2021 - 2030 (USD Million) 13.3.8 South Korea 13.3.8.1 South Korea Market, by Device Type, 2021 - 2030 (USD Million) Figure 97: South Korea Market, by Device Type, 2021 - 2030 (USD Million) 13.3.8.2 South Korea Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 98: South Korea Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.3.8.3 South Korea Market, by Technology, 2021 - 2030 (USD Million) Figure 99: South Korea Market, by Technology, 2021 - 2030 (USD Million) 13.3.9 Rest of APAC 13.3.9.1 Rest of APAC Market, by Device Type, 2021 - 2030 (USD Million) Figure 100: Rest of APAC Market, by Device Type, 2021 - 2030 (USD Million) 13.3.9.2 Rest of APAC Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 101: Rest of APAC Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.3.9.3 Rest of APAC Market, by Technology, 2021 - 2030 (USD Million) Figure 102: Rest of APAC Market, by Technology, 2021 - 2030 (USD Million) 13.4 Latin America Figure 103: Latin America Market, By Revenue Forecast (2021-2030) 13.4.1 Latin America Market, by country, 2021 - 2030 (USD Million) Table 25: Latin America Market, by country, 2021 - 2030 (USD Million) Figure 104: Latin America Market, by country, 2021 - 2030 (USD Million) 13.4.2 Latin America Market, by Device Type, 2021 - 2030 (USD Million) Table 26: Latin America Market, by Device Type, 2021 - 2030 (USD Million) Figure 105: Latin America Market, by Device Type, 2021 - 2030 (USD Million) 13.4.3 Latin America Market, by Closing Mechanism, 2021 - 2030 (USD Million) Table 27: Latin America Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 106: Latin America Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.4.4 Latin America Market, by Technology, 2021 - 2030 (USD Million) Table 28: Latin America Market, by Technology, 2021 - 2030 (USD Million) Figure 107: Latin America Market, by Technology, 2021 - 2030 (USD Million) 13.4.5 Brazil 13.4.5.1 Brazil Market, by Device Type, 2021 - 2030 (USD Million) Figure 108: Brazil Market, by Device Type, 2021 - 2030 (USD Million) 13.4.5.2 Brazil Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 109: Brazil Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.4.5.3 Brazil Market, by Technology, 2021 - 2030 (USD Million) Figure 110: Brazil Market, by Technology, 2021 - 2030 (USD Million) 13.4.6 Mexico 13.4.6.1 Mexico Market, by Device Type, 2021 - 2030 (USD Million) Figure 111: Mexico Market, by Device Type, 2021 - 2030 (USD Million) 13.4.6 2 Mexico Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 112: Mexico Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.4.6.3 Mexico Market, by Technology, 2021 - 2030 (USD Million) Figure 113: Mexico Market, by Technology, 2021 - 2030 (USD Million) 13.4.6.4 Mexico Market, by By Technology, 2021 - 2030 (USD Million) Figure 114: Mexico Market, by By Technology, 2021 - 2030 (USD Million) 13.4.7 Rest of the Latin America 13.4.7.1 Rest of the Latin America Market, by Device Type, 2021 - 2030 (USD Million) Figure 115: Rest of the Latin America Market, by Device Type, 2021 - 2030 (USD Million) 13.4.7.2 Rest of the Latin America Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 116: Rest of the Latin America Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.4.7.3 Rest of the Latin America Market, by Technology, 2021 - 2030 (USD Million) Figure 117: Rest of the Latin America Market, by Technology, 2021 - 2030 (USD Million) 13.5 MEA Figure 118: MEA Market, By Revenue Forecast (2021-2030) 13.5.1 MEA Market, by Device Type, 2021 - 2030 (USD Million) Figure 119: MEA Market, by Device Type, 2021 - 2030 (USD Million) 13.5.2 MEA Market, by Closing Mechanism, 2021 - 2030 (USD Million) Figure 120: MEA Market, by Closing Mechanism, 2021 - 2030 (USD Million) 13.5.3 MEA Market, by Technology, 2021 - 2030 (USD Million) Figure 121: MEA Market, by Technology, 2021 - 2030 (USD Million) 13.5.4 MEA Market, by By Technology, 2021 - 2030 (USD Million) Figure 122: MEA Market, by By Technology, 2021 - 2030 (USD Million) Chapter 14. Competitive Landscape 14.1 Dickinson and Company. 14.1.1 Company overview 14.1.2 Financial performance 14.1.3 Product Portfolio Analysis 14.1.4 Business Strategy & Recent Development 14.2 Becton. 14.2 .1 Company overview 14.2 .2 Financial performance 14.2 .3 Product Portfolio Analysis 14.2 .4 Business Strategy & Recent Development 14.3 Corvida Medical. 14.3.1 Company overview 14.3.2 Financial performance 14.3.3 Product Portfolio Analysis 14.3.4 Business Strategy & Recent Development 14.4 B. Braun Melsungen. 14.4.1 Company overview 14.4.2 Financial performance 14.4.3 Product Portfolio Analysis 14.4.4 Business Strategy & Recent Development 14.5 ICU Medical. 14.5.1 Company overview 14.5.2 Financial performance 14.5.3 Product Portfolio Analysis 14.5.4 Business Strategy & Recent Development 14.6 JMS. 14.6.1 Company overview 14.6.2 Financial performance 14.6.3 Product Portfolio Analysis 14.6.4 Business Strategy & Recent Development 14.7 Equashield. 14.7.1 Company overview 14.7.2 Financial performance 14.7.3 Product Portfolio Analysis 14.7.4 Business Strategy & Recent Development 14.8 Corvida Medical. 14.8.1 Company overview 14.8.2 Financial performance 14.8.3 Product Portfolio Analysis 14.8.4 Business Strategy & Recent Development 14.9 Yukon Medical. 14.9.1 Company overview 14.9.2 Financial performance 14.9.3 Product Portfolio Analysis 14.9.4 Business Strategy & Recent Development 14.10 Simplivia Healthcare. 14.10.1 Company overview 14.10.2 Financial performance 14.10.3 Product Portfolio Analysis 14.10.4 Business Strategy & Recent Development 14.11 CODAN Medizinische Geräte. 14.11.1 Company overview 14.11.2 Financial performance 14.11.3 Product Portfolio Analysis 14.11.4 Business Strategy & Recent Development 14.12 Caragen. 14.12.1 Company overview 14.12.2 Financial performance 14.12.3 Product Portfolio Analysis 14.12.4 Business Strategy & Recent Development 14.13 VICTUS. 14.13.1 Company overview 14.13.2 Financial performance 14.13.3 Product Portfolio Analysis 14.13.4 Business Strategy & Recent Development 14.14 Baxter International. 14.14.1 Company overview 14.14.2 Financial performance 14.14.3 Product Portfolio Analysis 14.14.4 Business Strategy & Recent Development